# Product Requirements Document (PRD)

**Project:** MedRAG
**Version:** 0.1.0
**Status:** Sprint 0 – Phase 1
**Owner:** Swapnil
**Last Updated:** June 2026

---

# 1. Executive Summary

## Overview

MedRAG is a production-grade Retrieval-Augmented Generation (RAG) platform designed to answer biomedical questions using trusted scientific literature. Unlike general-purpose AI assistants, MedRAG grounds every response in retrieved evidence from authoritative biomedical sources and provides transparent citations for verification.

The platform is engineered to support researchers, clinicians, pharmaceutical scientists, and AI engineers by combining modern information retrieval techniques with large language models in a modular, observable, and reproducible architecture.

## Purpose

The exponential growth of biomedical publications has made it increasingly difficult for professionals to efficiently locate, evaluate, and synthesize relevant evidence. MedRAG addresses this challenge by providing a reliable AI-assisted literature search and question-answering system that emphasizes transparency, traceability, and scientific rigor.

## Value Proposition

MedRAG enables users to:

* Retrieve relevant biomedical literature using hybrid search.
* Receive evidence-grounded answers with citations.
* Explore retrieved documents and supporting context.
* Evaluate AI performance using standardized RAG metrics.
* Monitor and improve system performance through observability and experiment tracking.

---

# 2. Problem Statement

Biomedical knowledge is expanding at an unprecedented rate. Researchers and clinicians often struggle with:

* locating relevant literature efficiently
* filtering high-quality evidence
* synthesizing findings across multiple publications
* verifying AI-generated responses
* reproducing search workflows
* tracking information provenance

General-purpose LLMs frequently hallucinate medical information, omit citations, or provide unverifiable answers, making them unsuitable for evidence-based scientific workflows.

MedRAG aims to bridge this gap by integrating retrieval, generation, evaluation, and monitoring into a single engineering platform.

---

# 3. Vision Statement

To build a trustworthy, transparent, and extensible biomedical AI platform that empowers evidence-based research through reliable retrieval, citation-backed generation, and continuous evaluation.

---

# 4. Product Objectives

## Primary Objectives

* Build an end-to-end biomedical RAG system.
* Deliver trustworthy, citation-backed answers.
* Support scalable literature retrieval.
* Provide measurable retrieval and generation quality.
* Demonstrate production-grade AI engineering practices.

## Secondary Objectives

* Serve as a reference implementation for modern RAG architectures.
* Enable rapid experimentation with retrieval and LLM components.
* Facilitate future research in biomedical AI systems.

---

# 5. Target Users

## 5.1 Biomedical Research Scientist

### Goals

* Discover relevant publications quickly.
* Compare findings across multiple studies.
* Validate evidence supporting conclusions.

### Pain Points

* Information overload.
* Time-consuming manual searches.
* Difficulty identifying the most relevant papers.

### Success Criteria

* Accurate retrieval.
* Transparent citations.
* Fast response times.

---

## 5.2 Pharmaceutical Scientist

### Goals

* Investigate drug mechanisms.
* Explore therapeutic targets.
* Review recent discoveries.

### Pain Points

* Fragmented literature.
* Complex terminology.
* Rapidly evolving research.

### Success Criteria

* High-quality retrieval.
* Comprehensive evidence summaries.

---

## 5.3 Clinician

### Goals

* Review recent medical evidence.
* Validate treatment information.
* Access trustworthy references.

### Pain Points

* Limited time.
* Need for verifiable sources.
* Risk of misinformation.

### Success Criteria

* Reliable citations.
* Concise summaries.
* Evidence transparency.

---

## 5.4 Graduate Student

### Goals

* Learn unfamiliar biomedical topics.
* Conduct literature reviews.
* Explore research directions.

### Pain Points

* Large volume of papers.
* Limited domain expertise.
* Difficulty evaluating evidence.

### Success Criteria

* Easy-to-understand explanations.
* Linked source material.

---

## 5.5 AI Engineer

### Goals

* Benchmark retrieval systems.
* Experiment with RAG pipelines.
* Evaluate model performance.

### Pain Points

* Lack of reproducible pipelines.
* Limited observability.
* Poor evaluation tooling.

### Success Criteria

* Modular architecture.
* Standardized metrics.
* Experiment tracking.

---

# 6. User Stories

### Retrieval

* As a researcher, I want to search biomedical literature using natural language.
* As a researcher, I want semantic search to find relevant papers beyond keyword matching.
* As a clinician, I want recent publications to appear prominently.
* As a student, I want explanations linked to source papers.

### Question Answering

* As a pharmaceutical scientist, I want citation-backed answers.
* As a clinician, I want unsupported claims avoided.
* As a researcher, I want answers synthesized across multiple papers.
* As a student, I want concise summaries before detailed explanations.

### Exploration

* As a researcher, I want metadata for retrieved papers.
* As a researcher, I want publication dates and journals.
* As a researcher, I want document relevance rankings.

### Evaluation

* As an AI engineer, I want retrieval metrics recorded.
* As an AI engineer, I want generation quality evaluated automatically.
* As an AI engineer, I want experiment history preserved.

### Administration

* As a developer, I want to re-index literature without affecting APIs.
* As a developer, I want configurable retrieval parameters.
* As a maintainer, I want monitoring dashboards.

---

# 7. Functional Requirements

## 7.1 Literature Ingestion

The system shall:

* ingest PubMed metadata
* ingest PubMed Central articles
* extract metadata
* validate downloaded documents
* support incremental ingestion
* maintain ingestion logs

---

## 7.2 Document Processing

The system shall:

* clean extracted text
* remove boilerplate
* preserve document structure
* generate metadata
* split documents into optimized chunks

---

## 7.3 Embedding Generation

The system shall:

* generate dense embeddings
* support batch embedding
* version embedding models
* cache embeddings where appropriate

---

## 7.4 Indexing

The system shall:

* store vectors in Qdrant
* support metadata filtering
* support re-indexing
* maintain index consistency

---

## 7.5 Retrieval

The retrieval engine shall support:

* BM25 retrieval
* Dense retrieval
* Hybrid retrieval
* Configurable Top-K retrieval
* Metadata filtering
* Score normalization

---

## 7.6 Reranking

The system shall:

* rerank retrieved candidates
* improve retrieval precision
* expose reranking scores
* allow reranker replacement

---

## 7.7 Answer Generation

The generation module shall:

* synthesize retrieved evidence
* cite supporting documents
* avoid unsupported claims
* produce structured responses

---

## 7.8 Evaluation

The system shall compute:

* Faithfulness
* Context Precision
* Context Recall
* Answer Relevancy
* Retrieval metrics
* Hallucination indicators

---

## 7.9 Monitoring

The platform shall record:

* latency
* retrieval traces
* prompts
* token usage
* LLM outputs
* evaluation results

---

## 7.10 API

The backend shall expose endpoints for:

* document ingestion
* search
* question answering
* evaluation
* health checks
* system status

---

# 8. Non-Functional Requirements

## Performance

* Median retrieval latency < 500 ms
* End-to-end response latency < 8 seconds (excluding model download)
* Support concurrent users without significant degradation

## Reliability

* Graceful error handling
* Idempotent ingestion
* Consistent indexing

## Scalability

* Horizontal scaling of API services
* Independent retrieval services
* Modular storage backend

## Maintainability

* Modular architecture
* High documentation quality
* Consistent coding standards

## Testability

* Unit tests
* Integration tests
* End-to-end tests
* Regression tests

## Observability

* Distributed tracing
* Structured logging
* Metrics collection

## Security

* Environment-based secrets
* Input validation
* Dependency management

## Reproducibility

* Versioned datasets
* Versioned prompts
* Versioned models
* Experiment tracking

---

# 9. AI System Requirements

Every generated response must:

* be grounded in retrieved context
* include supporting citations
* avoid fabricated references
* indicate insufficient evidence when necessary
* remain deterministic where feasible
* preserve factual consistency

The system shall never intentionally generate unsupported biomedical claims.

---

# 10. MVP Scope

## Included

* PubMed ingestion
* PMC ingestion (selected articles)
* Document chunking
* Dense embeddings
* BM25 retrieval
* Hybrid retrieval
* Qdrant vector storage
* BGE reranker
* Citation-backed generation
* FastAPI backend
* Next.js frontend
* MLflow experiment tracking
* Phoenix observability
* Docker deployment
* Automated testing
* CI/CD

## Excluded

* Knowledge graphs
* Fine-tuned biomedical LLMs
* Multi-agent workflows
* Clinical decision support
* EHR integration
* Mobile application
* Multi-language support
* User authentication (initial MVP)

---

# 11. Success Metrics

## Retrieval

* Recall@K
* Precision@K
* Mean Reciprocal Rank (MRR)
* nDCG

## Generation

* Faithfulness
* Context Precision
* Context Recall
* Answer Relevancy

## Engineering

* Test coverage > 85%
* CI success rate > 95%
* Zero critical linting errors
* Complete documentation for all modules

## Operational

* API uptime during development > 99%
* Median API latency < 8 seconds
* Successful ingestion completion rate > 99%

---

# 12. Risks

| Risk                   | Impact | Mitigation                            |
| ---------------------- | ------ | ------------------------------------- |
| Hallucinated responses | High   | Retrieval grounding, RAGAS evaluation |
| Poor chunking          | High   | Iterative benchmarking                |
| Embedding model drift  | Medium | Model versioning                      |
| Retrieval latency      | Medium | Caching, optimization                 |
| API schema changes     | Medium | Versioned adapters                    |
| Large indexing costs   | Medium | Incremental indexing                  |

---

# 13. Constraints

* Preference for open-source technologies.
* Local-first development workflow.
* Dockerized deployment.
* GPU optional for development.
* Reproducible environments using `uv`.
* Biomedical data sourced from publicly available repositories.

---

# 14. Assumptions

* Biomedical APIs remain accessible.
* Users have internet connectivity for retrieval.
* Selected embedding models remain publicly available.
* Vector database storage is sufficient for MVP scale.
* Evaluation datasets are representative of real-world queries.

---

# 15. Future Roadmap

Potential future enhancements include:

* Multi-modal retrieval
* Figure and table understanding
* Biomedical knowledge graph integration
* Agentic literature review workflows
* Personalized research workspaces
* Continuous indexing of newly published papers
* Citation recommendation engine
* Clinical guideline retrieval
* Drug discovery workflow integration
* Multi-language biomedical support

---

# 16. Acceptance Criteria

The MVP is considered complete when a user can:

1. Submit a biomedical question.
2. Retrieve relevant literature using hybrid search.
3. View reranked supporting documents.
4. Receive a citation-backed generated answer.
5. Inspect retrieved evidence.
6. Access evaluation metrics.
7. View observability traces.
8. Run the complete system locally using Docker with documented setup instructions.

---

# 17. Release Strategy

## Alpha

* Internal engineering validation
* Component testing
* Retrieval benchmarking

## Beta

* End-to-end workflows
* Performance optimization
* Expanded evaluation

## Version 1.0

* Stable API
* Complete documentation
* Production-ready deployment
* Public GitHub release

---

# 18. Out of Scope

The following capabilities are explicitly excluded from Version 1.0:

* Medical diagnosis
* Treatment recommendations
* Prescription generation
* Regulatory compliance certifications
* Real-time hospital integrations
* Patient-specific clinical decision support

These features require additional validation, governance, and regulatory considerations beyond the scope of this project.

---

# 19. Definition of Product Success

MedRAG will be considered successful when it:

* Provides trustworthy, evidence-grounded answers with transparent citations.
* Demonstrates measurable improvements in retrieval and generation quality.
* Serves as a production-grade reference implementation for biomedical RAG systems.
* Enables reproducible experimentation through modular architecture and comprehensive evaluation.
* Is maintainable, extensible, and well-documented for future contributors and research extensions.
